GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Tecon Biology Co Ltd (SZSE:002100) » Definitions » Equity-to-Asset

Tecon Biology Co (SZSE:002100) Equity-to-Asset : 0.37 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tecon Biology Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Tecon Biology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥6,412 Mil. Tecon Biology Co's Total Assets for the quarter that ended in Mar. 2024 was ¥17,167 Mil. Therefore, Tecon Biology Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.37.

The historical rank and industry rank for Tecon Biology Co's Equity-to-Asset or its related term are showing as below:

SZSE:002100' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34   Med: 0.45   Max: 0.66
Current: 0.37

During the past 13 years, the highest Equity to Asset Ratio of Tecon Biology Co was 0.66. The lowest was 0.34. And the median was 0.45.

SZSE:002100's Equity-to-Asset is ranked worse than
72.72% of 1928 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs SZSE:002100: 0.37

Tecon Biology Co Equity-to-Asset Historical Data

The historical data trend for Tecon Biology Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecon Biology Co Equity-to-Asset Chart

Tecon Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.39 0.41 0.41 0.38

Tecon Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.39 0.43 0.38 0.37

Competitive Comparison of Tecon Biology Co's Equity-to-Asset

For the Packaged Foods subindustry, Tecon Biology Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tecon Biology Co's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Tecon Biology Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Tecon Biology Co's Equity-to-Asset falls into.



Tecon Biology Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Tecon Biology Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=6410.601/16751.66
=0.38

Tecon Biology Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=6411.813/17166.609
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tecon Biology Co  (SZSE:002100) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Tecon Biology Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Tecon Biology Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecon Biology Co (SZSE:002100) Business Description

Traded in Other Exchanges
N/A
Address
High-tech Zone in Changchun Road, 528 Tiankang Business Building, Xinjiang, Urumqi, CHN, 830011
Tecon Biology Co Ltd is engaged in the production and sales of veterinary biological products and animal disease prevention, modern pig science breeding and breeding, feed research and development and production, and pig slaughtering and processing. The company mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
Executives
Wang Xiao Supervisors
Pan Yi Ping Executives
Xu Heng Executives
Wu Xiang Yong Director
Sun Wei Hong Independent director
Wu Ming Qi Executives
Wang Xin An Director
Geng Li Xin Directors, executives
Che Xin Hui Supervisors

Tecon Biology Co (SZSE:002100) Headlines

No Headlines